[Form 4] INVO Fertility, Inc. Insider Trading Activity
Steven Shum, listed as Chief Executive Officer and a Director of INVO Fertility, Inc. (IVF), filed a Form 4 reporting an equity compensation transaction dated 08/26/2025. The filing shows a grant of a stock option with an exercise price of $1.01 covering 42,000 underlying shares, exercisable through 08/26/2035. The option vests in four equal installments beginning on the first day of the calendar quarter following 08/26/2025 and on the first day of each calendar quarter thereafter until fully vested. Following the reported transaction, the filing lists beneficial ownership of 42,451 shares of common stock held directly.
Steven Shum, menzionato come Chief Executive Officer e Director di INVO Fertility, Inc. (IVF), ha presentato un Modulo 4 riportando una transazione di compensazione azionaria datata 08/26/2025. La compilazione indica la concessione di una opzione su azioni con prezzo di esercizio di $1.01 che copre 42.000 azioni sottostanti, eseguibile fino al 08/26/2035. L’opzione matura in quattro.rate uguali a partire dal primo giorno del trimestre solare successivo al 08/26/2025 e dal primo giorno di ogni trimestre solare successivo fino al completely vested. Dopo la transazione riportata, la compilazione indica una proprietà beneficia di 42.451 azioni ordinarie detenute direttamente.
Steven Shum, mencionado como Director Ejecutivo y un Director de INVO Fertility, Inc. (IVF), presentó un Formulario 4 que reporta una transacción de compensación en acciones fechada el 26/08/2025. La presentación muestra la concesión de una opción de compra de acciones con un precio de ejercicio de $1.01 que cubre 42,000 acciones subyacentes, ejercible hasta el 26/08/2035. La opción se consolida en cuatro cuotas iguales que comienzan el primer día del trimestre calendario posterior al 26/08/2025 y el primer día de cada trimestre calendario subsiguiente hasta que esté completamente vestida. Tras la transacción reportada, la presentación indica una propiedad beneficiosa de 42,451 acciones comunes directamente poseídas.
Steven Shum은 INVO Fertility, Inc. (IVF)의 Chief Executive Officer 및 Director로 기재되었으며, 08/26/2025로 날짜가 된 자본 보상 거래를 보고한 Form 4를 제출했습니다. 첨부 파일에는 행사가격 $1.01의 주식매수선택권이 아래의 42,000주의 주식을 커버하며 2035년 8월 26일까지 exercisable으로 표시됩니다. 이 옵션은 2025년 8월 26일 이후의 각 달력 분기 첫날부터 시작하여 매 분기 첫째 날마다 네 차례의 동일한 분할로 vesting되며, 완전히 vest될 때까지 지속됩니다. 보고된 거래 이후, 첨부 파일에는 42,451주의 보통주를 직접 보유한 유익한 소유권이 기재되어 있습니다.
Steven Shum, mentionné comme Directeur Général et Administrateur de INVO Fertility, Inc. (IVF), a déposé un Formulaire 4 déclarant une opération de compensation en actions datée du 26/08/2025. Le dépôt indique l’octroi d’une option d’achat d’actions avec un prix d’exercice de $1,01 couvrant 42 000 actions sous-jacentes, exercitable jusqu’au 26/08/2035. L’option se vest en quatre versements égaux à partir du premier jour du trimestre civil suivant le 26/08/2025 et au premier jour de chaque trimestre civil par la suite jusqu’à ce qu’elle soit entièrement acquise. Après la transaction reportée, le dépôt indique une propriété bénéficiaire de 42 451 actions ordinaires détenues directement.
Steven Shum, aufgeführt als Chief Executive Officer und Direktor von INVO Fertility, Inc. (IVF), hat ein Form 4 eingereicht, das eine Transaktion der Eigenkapitalvergütung vom 26.08.2025 meldet. Die Einreichung zeigt die Gewährung einer Aktienoption mit einem Ausübungspreis von $1,01, die 42.000 zugrunde liegende Aktien abdeckt und bis zum 26.08.2035 ausgeübt werden kann. Die Option vestet in vier gleichen Raten, beginnend am ersten Tag des auf den 26.08.2025 folgenden Kalenderquartals und am ersten Tag jedes nachfolgenden Kalenderquartals, bis sie vollständig vestet ist. Nach der gemeldeten Transaktion listet die Einreichung eine indirekte Beneficial Ownership von 42.451 Stammaktien, direkt gehalten.
Steven Shum، المذكور كـ الرئيس التنفيذي و مدير لـ INVO Fertility, Inc. (IVF)، قدم نموذج 4 يقر بصفقة تعويض بالأسهم بتاريخ 26/08/2025. تُظهر الشكوى منح خيار أسهم بسعر ممارسة قدره $1.01 يغطي 42,000 سهمًا أساسيًا، قابل للممارسة حتى 26/08/2035. يصبح الخيار vested على أربع دفعات متساوية ابتداءً من اليوم الأول من الربع التقويمي التالي لـ 26/08/2025، ثم في اليوم الأول من كل ربع تقويمي لاحق حتى يتم vestingه بالكامل. عقب الصفقة المذكورة، تسجل الشكوى امتلاكاً مستفيداً لـ 42,451 سهمًا عاديًا مملوكاً بشكل مباشر.
Steven Shum，被列为INVO Fertility, Inc. (IVF)的首席执行官和董事，已提交一份
- 42,000 stock options granted with an explicit vesting schedule
- Option grant has a clear expiration date of 08/26/2035
- Filing discloses 42,451 shares beneficially owned following the transaction
- Grant increases potential share count by 42,000 underlying shares
- Vesting begins after the grant date, so not immediately exercisable
Insights
Insider option grant with multi‑quarter vesting and a 10‑year term.
The Form 4 confirms a 42,000 stock option award to Steven Shum dated 08/26/2025 with an exercise price of $1.01 and an expiration of 08/26/2035. The disclosed vesting schedule begins the first calendar quarter after the grant and vests in four equal installments, which is a time‑based retention structure.
The filing also shows 42,451 shares beneficially owned following the transaction, reported as direct ownership. These are explicit, reportable changes under Section 16 and are relevant to governance and disclosure oversight.
Grant details indicate the option is low‑strike and long‑dated.
The option's $1.01 strike and 10‑year lifespan (expiration 08/26/2035) are stated verbatim in the filing and define the contract terms available to the reporting person. Vesting in four equal quarterly installments beginning after 08/26/2025 is a factual schedule disclosed in the explanation.
No cash amounts paid or exercised are disclosed in the form; the document only reports the grant and resulting beneficial ownership figures.
Steven Shum, menzionato come Chief Executive Officer e Director di INVO Fertility, Inc. (IVF), ha presentato un Modulo 4 riportando una transazione di compensazione azionaria datata 08/26/2025. La compilazione indica la concessione di una opzione su azioni con prezzo di esercizio di $1.01 che copre 42.000 azioni sottostanti, eseguibile fino al 08/26/2035. L’opzione matura in quattro.rate uguali a partire dal primo giorno del trimestre solare successivo al 08/26/2025 e dal primo giorno di ogni trimestre solare successivo fino al completely vested. Dopo la transazione riportata, la compilazione indica una proprietà beneficia di 42.451 azioni ordinarie detenute direttamente.
Steven Shum, mencionado como Director Ejecutivo y un Director de INVO Fertility, Inc. (IVF), presentó un Formulario 4 que reporta una transacción de compensación en acciones fechada el 26/08/2025. La presentación muestra la concesión de una opción de compra de acciones con un precio de ejercicio de $1.01 que cubre 42,000 acciones subyacentes, ejercible hasta el 26/08/2035. La opción se consolida en cuatro cuotas iguales que comienzan el primer día del trimestre calendario posterior al 26/08/2025 y el primer día de cada trimestre calendario subsiguiente hasta que esté completamente vestida. Tras la transacción reportada, la presentación indica una propiedad beneficiosa de 42,451 acciones comunes directamente poseídas.
Steven Shum은 INVO Fertility, Inc. (IVF)의 Chief Executive Officer 및 Director로 기재되었으며, 08/26/2025로 날짜가 된 자본 보상 거래를 보고한 Form 4를 제출했습니다. 첨부 파일에는 행사가격 $1.01의 주식매수선택권이 아래의 42,000주의 주식을 커버하며 2035년 8월 26일까지 exercisable으로 표시됩니다. 이 옵션은 2025년 8월 26일 이후의 각 달력 분기 첫날부터 시작하여 매 분기 첫째 날마다 네 차례의 동일한 분할로 vesting되며, 완전히 vest될 때까지 지속됩니다. 보고된 거래 이후, 첨부 파일에는 42,451주의 보통주를 직접 보유한 유익한 소유권이 기재되어 있습니다.
Steven Shum, mentionné comme Directeur Général et Administrateur de INVO Fertility, Inc. (IVF), a déposé un Formulaire 4 déclarant une opération de compensation en actions datée du 26/08/2025. Le dépôt indique l’octroi d’une option d’achat d’actions avec un prix d’exercice de $1,01 couvrant 42 000 actions sous-jacentes, exercitable jusqu’au 26/08/2035. L’option se vest en quatre versements égaux à partir du premier jour du trimestre civil suivant le 26/08/2025 et au premier jour de chaque trimestre civil par la suite jusqu’à ce qu’elle soit entièrement acquise. Après la transaction reportée, le dépôt indique une propriété bénéficiaire de 42 451 actions ordinaires détenues directement.
Steven Shum, aufgeführt als Chief Executive Officer und Direktor von INVO Fertility, Inc. (IVF), hat ein Form 4 eingereicht, das eine Transaktion der Eigenkapitalvergütung vom 26.08.2025 meldet. Die Einreichung zeigt die Gewährung einer Aktienoption mit einem Ausübungspreis von $1,01, die 42.000 zugrunde liegende Aktien abdeckt und bis zum 26.08.2035 ausgeübt werden kann. Die Option vestet in vier gleichen Raten, beginnend am ersten Tag des auf den 26.08.2025 folgenden Kalenderquartals und am ersten Tag jedes nachfolgenden Kalenderquartals, bis sie vollständig vestet ist. Nach der gemeldeten Transaktion listet die Einreichung eine indirekte Beneficial Ownership von 42.451 Stammaktien, direkt gehalten.
FAQ
What did Steven Shum (IVF) report on Form 4?
When does the option granted to IVF's CEO vest and expire?
How many shares does Steven Shum beneficially own after the reported transaction?
What is the exercise price of the option on the Form 4 for IVF?
Was the Form 4 filed individually or jointly?
